Class II · Moderate risk
ESTRIOL Suppositories
Penicillin Cross Contamination: potentially contaminated with penicillin
FDA Drug Recalls
1,464 recalls · Class II, newest first
Class II · Moderate risk
ESTRIOL Vaginal Creams
Penicillin Cross Contamination: potentially contaminated with penicillin
Class II · Moderate risk
ESTRIOL Capsules
Penicillin Cross Contamination: potentially contaminated with penicillin
Class II · Moderate risk
HYDROXOCOBALAMIN Injection
Penicillin Cross Contamination: potentially contaminated with penicillin
Class II · Moderate risk
E3 Cream
Penicillin Cross Contamination: potentially contaminated with penicillin
Class II · Moderate risk
2-DEOXY-D-GLUCOSE Powder
Penicillin Cross Contamination: potentially contaminated with penicillin
Class II · Moderate risk
Rifampin for Injection
Failed Impurities/Degradation Specifications; out-of-specification for color, impurity, and degradation
Class II · Moderate risk
Heparin Sodium and 0.9% Sodium Chloride Injection
Subpotent Drug; out of specification results for heparin raw material
Class II · Moderate risk
Tri-Mix T-50/PGE 2/LIDO 2 0.09/0.32/0.04 Injectable
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix T-50/PGE 2/LIDO 2 0.03/0.18/0.09 Injectable
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix T-50/PGE 1 0.14/0.08 Injectable
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix T-50 8.8 mg/0.29 mg/2.9 mcg Injectable
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix T-106/PGE 2 0.1/0.14 Injectable
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix T-106
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix T-105
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix T-102/PGE 2/LIDO 2 0.06/0.3/0.2 Injectable
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix T-102
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix T-101
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix SUPER
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix ST9E
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix ST9C
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix ST9A
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix ST9A
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix ST4/PGE 2/LIDO 2 0.1/0.05/0.05 Injectable
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Tri-Mix ST4
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility